HuagongsheHuagongshe Chemistry Print Report · For research reference only
(1S,2R,3S,5R)-3-(di-tert-butoxycarbonylamino)-5-(2,6-dichloro-purin-9-yl)-cyclopentane-1,2-diol → (1R,2S,3R,5S)-3-(2,6-Dichloro-purin-9-yl)-5-(4-ethyl-[1,2,3]triazol-2-yl)-cyclopentane-1,2-diol
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (1S,2R,3S,5R)-3-(di-tert-butoxycarbonylamino)-5-(2,6-dichloro-purin-9-yl)-cyclopentane-1,2-diol | HCID 57777515 | — |
| Reactant | 2,6-Dichloro-9-[(1R,4S)-4-(4-ethyl-[1,2,3]triazol-2-yl)-cyclopent-2-enyl]-9H-purine | HCID 86643672 | — |
| Product | (1R,2S,3R,5S)-3-(2,6-Dichloro-purin-9-yl)-5-(4-ethyl-[1,2,3]triazol-2-yl)-cyclopentane-1,2-diol | HCID 86643673 | — |
Reaction Steps
The titled compound is prepared analogously to (1S,2R,3S,5R)-3-(di-Boc-amino)-5-(2,6-dichloro-purin-9-yl)-cyclopentane-1,2-diol (AA4) by replacing di-Boc-[(1S,4R)-4-(2,6-dichloro-purin-9-yl)-cyclopent-2-enyl]-amine with 2,6-dichloro-9-[(1R,4S)-4-(4-ethyl-[1,2,3]triazol-2-yl)-cyclopent-2-enyl]-9H-purine (Step 1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08193164B2 |
| Source dataset | uspto-grants-2012_06 |
| ORD ID | ord-b84562ffcbe54167b4bb020c6f85cd3d |
| Source note | uspto-grants-2012_06 |